Literature DB >> 18433892

Effects of the genetic background on cognitive performances of TG2576 mice.

Jean Michel Lassalle1, Hélène Halley, Stéphanie Daumas, Laure Verret, Bernard Francés.   

Abstract

Animal models of genetic diseases obtained by transferring human mutated genes in the mouse are widely used in biomedical based research. They constitute efficient tools to study mechanisms underlying abnormal phenotypes. Unfortunately, the phenotype of the transgene is often obscured by the genetic background of the embryonic stem cells and that of the recipient strain used to create the transgenic line. It is also known, from the literature, that repeatedly backcrossing a transgenic strain to an inbred background may have unfavorable effects that can result in the loss of the transgenic line. In order to analyze the influences of the genetic background on the transgene expression, we studied the effects of the hAPPswe transgene involved in Alzheimer's Amyloid Pathology, in 3 genetic backgrounds differing by their genetic heterogeneity (homozygous vs heterozygous) and the strain of origin (C57BL6, CBA, B6SJL F1) after only one generation backcrossing. Three different behavioral paradigms were used to assess the psychological and cognitive phenotypic differences: elevated plus maze, morris navigation task and contextual fear conditioning. Our data indicate that the best solution to maintain the transgenic line is to backcross repeatedly the transgenic mice into the F1 hybrid cross that was used to create the transgenic strain, whereas phenotyping should be performed comparatively after only one generation backcrossing into various well chosen F1 or inbred backgrounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433892     DOI: 10.1016/j.bbr.2008.03.017

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  14 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

3.  Generation of gene-targeted mice using embryonic stem cells derived from a transgenic mouse model of Alzheimer's disease.

Authors:  Satoshi Yamamoto; Yuki Ooshima; Mitsugu Nakata; Takashi Yano; Kunio Matsuoka; Sayuri Watanabe; Ryouta Maeda; Hideki Takahashi; Michiyasu Takeyama; Yoshio Matsumoto; Tadatoshi Hashimoto
Journal:  Transgenic Res       Date:  2012-09-09       Impact factor: 2.788

4.  Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.

Authors:  Brian A Couch; Meghan E Kerrisk; Adam C Kaufman; Haakon B Nygaard; Stephen M Strittmatter; Anthony J Koleske
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

5.  Of mice and men: bridging the translational disconnect in CNS drug discovery.

Authors:  Hugo Geerts
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

6.  Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research.

Authors:  K S Montgomery; R K Simmons; G Edwards; M M Nicolle; M A Gluck; C E Myers; J L Bizon
Journal:  Neurobiol Aging       Date:  2009-08-31       Impact factor: 4.673

7.  Metabolic parameters and emotionality are little affected in G-protein coupled receptor 12 (Gpr12) mutant mice.

Authors:  Elisabeth Frank; Yizhen Wu; Naomi Piyaratna; William James Body; Peta Snikeris; Timothy South; Anna-Karin Gerdin; Mikael Bjursell; Mohammad Bohlooly-Y; Leonard Storlien; Xu-Feng Huang
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

8.  Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.

Authors:  Zuzana Stozicka; Norbert Zilka; Petr Novak; Branislav Kovacech; Ondrej Bugos; Michal Novak
Journal:  J Neuroinflammation       Date:  2010-10-12       Impact factor: 8.322

Review 9.  Dissecting Alzheimer disease in Down syndrome using mouse models.

Authors:  Xun Yu Choong; Justin L Tosh; Laura J Pulford; Elizabeth M C Fisher
Journal:  Front Behav Neurosci       Date:  2015-10-13       Impact factor: 3.558

10.  Modifications of hippocampal circuits and early disruption of adult neurogenesis in the tg2576 mouse model of Alzheimer's disease.

Authors:  Alice Krezymon; Kevin Richetin; Hélène Halley; Laurent Roybon; Jean-Michel Lassalle; Bernard Francès; Laure Verret; Claire Rampon
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.